Eye care in Mays Landing. Twenty-six years of it, eight of them right here in Atlantic County, with the imaging and testing done here, not referred out.

About Dr. Khoury

Dr. Sam Khoury has worked in eye care for more than 26 years, the last eight of them in Atlantic County.

He is an independent doctor, which means the recommendation you get is his. The imaging and testing that answers those questions is done in this office rather than referred out, so a finding is usually resolved at the same visit instead of across three appointments and a month of waiting.

His clinical focus is on catching things early: retinal changes, the beginnings of glaucoma, corneal problems, and the eye findings that turn out to be a sign of something systemic. When a problem needs a surgeon or a subspecialist, he will tell you plainly, send you to someone specific, and make sure they have what they need before you arrive.

He also runs a dedicated myopia management program for children, described below.

What we do

• Comprehensive eye exams Refraction, assessment of how the eyes work together, pressure, and examination of the front of the eye and the retina. Retinal imaging is done without dilation in most cases, and pressure is measured without an air puff.
• Contact lens fittings Including astigmatism, multifocal, and hard-to-fit corneas. New wearers are taught insertion and removal in the office.
• Myopia management for children Measuring and slowing the progression of nearsightedness. See below.
• Diabetic eye exams Annual retinal evaluation with widefield imaging and cross-sectional scans that show swelling before it affects vision. A report goes back to your primary care doctor or endocrinologist.
• Glaucoma testing and monitoring Pressure, peripheral vision mapping, and layer-by-layer scans of the optic nerve, tracked over time so change is visible early.
• Dry eye evaluation and treatment Finding out which kind of dry eye you have before treating it, which is why drops alone often fail.
• Medication monitoring Baseline and interval screening for patients taking medications with known ocular risk, with findings reported back to the prescribing physician.
• Urgent eye problems Red eye, infection, something in your eye, a scratch, sudden floaters or flashes. Call — same-day slots are held.
• Glasses and lens prescriptions You are free to fill your prescription anywhere. We will give you a copy without asking why.

Myopia management for children

When a child's nearsightedness gets worse every year, that is not just an inconvenience. Higher myopia raises the lifetime risk of retinal detachment, glaucoma, and myopic macular degeneration. The prescription is a number, but it is also a risk factor.

Two treatments now carry FDA authorization for slowing myopia progression in children. MiSight 1 day is a daily disposable soft contact lens, authorized for children aged 8 to 12 at the start of treatment. Stellest is a spectacle lens, authorized in September 2025 for children aged 6 to 12 at the start of treatment — the first eyeglass lens cleared for this purpose in the United States. That matters for younger children and for anyone not ready to wear contacts.

Low-dose atropine drops are used selectively, where neither of those is a fit. The formulation is compounded rather than FDA-approved for myopia control, and consistency between batches varies.

None of these reverse myopia. They reduce how much further it goes.

We measure axial length — the actual front-to-back length of the eye — with a Topcon MYAH. That measurement is more sensitive than the glasses prescription alone, so it shows whether a treatment is working within months instead of years.

If your child's prescription changed noticeably at their last two exams, it is worth a conversation.

Monitoring for patients on long-term medications

A number of medications carry a known risk to the eye, and the damage is often silent until it is permanent. Screening exists to catch it while it can still be acted on. Most of these patients arrive by referral from the doctor who prescribed the drug.

Hydroxychloroquine (Plaquenil) carries a small but real risk of retinal toxicity that rises with cumulative dose and years of use. Screening calls for a baseline examination and annual screening after five years, using automated visual fields and OCT together — neither test alone is sufficient. Both are done here, and results go back to your rheumatologist.

GLP-1 medications — semaglutide and the drugs in that class, including Ozempic and Wegovy — place patients in an at-risk category under current AOA examination guidance, which calls for baseline assessment and closer follow-up intervals. Two things drive that. Rapid improvement in blood sugar can transiently worsen existing diabetic retinopathy, and an association has been reported with a sudden loss of blood flow to the optic nerve. That event remains rare and the causal picture is still being worked out, but sudden vision loss while taking these medications should be treated as an emergency, not held for the next appointment.

Similar monitoring applies to pentosan polysulfate (Elmiron), ethambutol, amiodarone, tamoxifen, vigabatrin, and long-term corticosteroids. If your prescribing doctor has asked for a baseline or an interval check, bring the request and the results will be sent back to them.

Visit

Book an exam

Serving Mays Landing, Egg Harbor Township, Hamilton Township, Galloway, Absecon, Northfield, Linwood, Somers Point, and Atlantic County.